CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,895,524 | -23.3% | 142,980 | -37.3% | 0.02% | -25.0% |
| Q2 2023 | $5,076,649 | +3.0% | 228,167 | +0.3% | 0.02% | -9.1% |
| Q1 2023 | $4,928,646 | +1197.6% | 227,546 | +1116.7% | 0.02% | +1000.0% |
| Q4 2022 | $379,838 | -20.2% | 18,702 | +0.8% | 0.00% | -33.3% |
| Q3 2022 | $476,000 | +163.0% | 18,555 | +143.1% | 0.00% | +200.0% |
| Q2 2022 | $181,000 | +18.3% | 7,632 | +12.2% | 0.00% | 0.0% |
| Q1 2022 | $153,000 | +112.5% | 6,805 | +87.8% | 0.00% | – |
| Q4 2021 | $72,000 | +9.1% | 3,624 | +7.6% | 0.00% | -100.0% |
| Q3 2021 | $66,000 | -9.6% | 3,368 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $73,000 | -23.2% | 3,331 | -16.2% | 0.00% | 0.0% |
| Q1 2021 | $95,000 | +1483.3% | 3,975 | +1706.8% | 0.00% | – |
| Q4 2020 | $6,000 | +200.0% | 220 | +83.3% | 0.00% | – |
| Q3 2020 | $2,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |